OM:VIMIANMedical Equipment
Vimian Group (OM:VIMIAN) Valuation Check After Strong 2025 Results And New Acquisitions
Vimian Group (OM:VIMIAN) is back in focus after its fourth quarter and full year 2025 earnings, where double digit revenue and adjusted EBITDA growth, along with a higher full year net income, drew fresh investor attention.
See our latest analysis for Vimian Group.
The earnings release and earlier 2025 earnings call seem to have reset sentiment, with the latest move to SEK27.94 coming after a 1 day share price return of 11.14%, against a weaker 1 year total shareholder return of 37% and a...